China Biotech Services Holdings Limited provided earnings guidance for the third quarter ended 30 September 2020. For the period, the company expects to record a net profit of not less than HKD 130,000,000 for the 2020 Third Quarter Period as compared to the net loss of approximately HKD 60,294,000 recorded for the corresponding period in 2019.